Department of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo 669, 5 Floor, São Paulo 04039-032, Brazil.
Int J Mol Sci. 2021 Aug 27;22(17):9319. doi: 10.3390/ijms22179319.
Tissue Inhibitor of Metalloproteases 1, also known as TIMP-1, is named for its well-established function of inhibiting the proteolytic activity of matrix metalloproteases. Given this function, many studies were carried out to verify if TIMP-1 was able to interrupt processes such as tumor cell invasion and metastasis. In contrast, many studies have shown that TIMP-1 expression is increased in several types of tumors, and this increase was correlated with a poor prognosis and lower survival in cancer patients. Later, it was shown that TIMP-1 is also able to modulate cell behavior through the induction of signaling pathways involved in cell growth, proliferation, and survival. The mechanisms involved in the regulation of the pleiotropic functions of TIMP-1 are still poorly understood. Thus, this review aimed to present literature data that show its ability to form a membrane complex with CD63 and β1-integrin, and point to glycosylation as a potential regulatory mechanism of the functions exerted by TIMP-1. This article reviewed the characteristics and functions performed individually by TIMP1, CD63, and β1-integrin, the roles of the TIMP-1/CD63/β1-integrin complex, both in a physiological context and in cancer, and the regulatory mechanisms involved in its assembly.
组织金属蛋白酶抑制剂 1(Tissue Inhibitor of Metalloproteases 1,也称为 TIMP-1)因其抑制基质金属蛋白酶(matrix metalloproteases)的蛋白水解活性的既定功能而得名。鉴于其功能,许多研究都旨在验证 TIMP-1 是否能够阻断肿瘤细胞侵袭和转移等过程。相比之下,许多研究表明 TIMP-1 在多种类型的肿瘤中表达增加,并且这种增加与癌症患者的预后不良和生存率降低相关。后来,研究表明 TIMP-1 还能够通过诱导参与细胞生长、增殖和存活的信号通路来调节细胞行为。TIMP-1 发挥其多效性功能的调节机制仍知之甚少。因此,本综述旨在介绍文献数据,这些数据表明 TIMP-1 能够与 CD63 和 β1-整合素形成膜复合物,并指出糖基化可能是调节 TIMP-1 功能的潜在机制。本文综述了 TIMP1、CD63 和 β1-整合素各自的特性和功能、TIMP-1/CD63/β1-整合素复合物在生理和癌症环境中的作用,以及其组装所涉及的调节机制。